U.S. Administration Seeks to Expedite Psychedelic Therapy Research

The Trump administration has issued an executive order aimed at accelerating the research, regulation, and integration of psychedelic-assisted therapies into the U.S. healthcare system. This initiative specifically focuses on addressing treatment-resistant mental health conditions like PTSD and depression, with a particular emphasis on supporting veterans. The action signifies a notable regulatory step toward expanding potential treatment options for these challenging conditions.